Zheng Xie

Zheng Xie


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
JCJun Cao
Jun Cao
ZSZhaohai Su
Zhaohai Su
JYJiangyong Yang
Jiangyong Yang
BZBilong Zhang
Bilong Zhang
RJRengui Jiang
Rengui Jiang
ZXZheng Xie
Zheng Xie
Objective: This study aims to investigate the relationship between the atherogenic index of plasma (AIP) and diabetes risk in Chinese non-obese adults. This is important because the incidence of diabetes is significant in non-obese populations, and evidence regarding this association is limited.Methods: We conducted a retrospective cohort study with 82,977 Chinese non-obese adults. We used Cox proportional hazards regression to assess the relationship between baseline AIP levels and diabetes incidence. We also employed cubic spline functions and smooth curve fitting to investigate potential nonlinear relationships. Sensitivity and subgroup analyses were conducted to validate our findings.Results: The median follow-up duration for these participants was 3.10 years, during which 1,041 subjects (1.25%) were diagnosed with diabetes. Adjusted analyses demonstrated a strong positive association between AIP and the risk of diabetes onset (HR 2.07; 95% CI: 1.63-2.63; p < 0.001). The risk of diabetes increased with higher AIP quartiles, especially between the highest (Q4) and lowest (Q1) quartiles (adjusted HR 1.55; 95% CI: 1.27-1.89). We also identified a nonlinear relationship between AIP and diabetes risk. Sensitivity and subgroup analyses confirmed these findings. Furthermore, E-value analysis indicated that the results were robust against unmeasured confounding variables.Conclusion: Our findings highlight a positive, nonlinear association between AIP and diabetes risk in Chinese non-obese adults. Lowering triglycerides (TG) or increasing high-density lipoprotein cholesterol (HDL-C) levels may help reduce this risk.

23 October 2024 in Functional & Integrative Genomics
Verified
Journal Article
Closed access
PDF file
JCJun Cao
Jun Cao
ZSZhaohai Su
Zhaohai Su
BZBilong Zhang
Bilong Zhang
JYJiangyong Yang
Jiangyong Yang
YWYueting Wang
Yueting Wang
WLWeiling Lu
Weiling Lu